Status:
COMPLETED
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
Lead Sponsor:
Amgen
Conditions:
Osteoporosis
Eligibility:
FEMALE
60-90 years
Phase:
PHASE3
Brief Summary
This study will evaluate the effectiveness and safety of denosumab in treating women with Postmenopausal Osteoporosis.
Eligibility Criteria
Inclusion
- Women who are 60 to 90 years of age may be eligible to participate
- Bone mineral density (BMD) T-Score at hip or spine must be less than -2.5
Exclusion
- BMD T-Score at the hip or the spine of less than -4.0
- Patients with any severe or more than two moderate vertebral fractures on spinal x-ray at entry
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2008
Estimated Enrollment :
7808 Patients enrolled
Trial Details
Trial ID
NCT00089791
Start Date
August 1 2004
End Date
June 17 2008
Last Update
November 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.